Chee Kong Choo insider trades

Open-market stock purchases and sales by Chee Kong Choo, Director, 10% Owner at CytoMed Therapeutics Ltd, from SEC Form 4 filings since May 13, 2026.

Recent trades

DateStockTradeValue
May 13, 2026GDTC CytoMed Therapeutics LtdBought$129K

Companies traded

  • GDTC CytoMed Therapeutics Ltd: 1 buy, last May 13, 2026

Get free alerts when Chee Kong Choo files a new trade →